# OnCo record jeffrey-lancet (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/jeffrey-lancet/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "jeffrey-lancet" ;
  schema:name "Jeffrey E. Lancet"@en ;
  schema:description "Florida leukaemia doctor who led the phase 3 trial of CPX-351, the liposomal form of daunorubicin and cytarabine that lengthened survival for older people with secondary acute myeloid leukaemia."@en ;
  schema:url <https://onco.cc/people/jeffrey-lancet/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "leukaemia", "trialist" ;
  schema:jobTitle "Haematologist, Moffitt Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/aml-secondary/>, <https://onco.cc/cancers/aml/> ;
  onco:institutions <https://onco.cc/institutions/moffitt/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-cpx-351-study-301-lancet-je-jco-2018/> ;
  schema:affiliation <https://onco.cc/institutions/moffitt/> .